Therapeutic Advances in Endocrinology and Metabolism
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 7.8 | Q1 | 91.5% | 1.642 | Q1 | 93.2% |
| 2024 | 4.6 | Q1 | 78.2% | 1.381 | Q1 | 91.0% |
| 2023 | 3.9 | Q2 | 71.5% | 1.301 | Q1 | 90.7% |
| 2022 | 3.8 | Q2 | 58.7% | 1.058 | Q1 | 87.5% |
| 2021 | 4.4 | Q2 | 64.8% | 0.922 | Q2 | 84.8% |
| 2020 | — | — | 0.889 | Q2 | 82.5% | |
| 2019 | — | — | 0.872 | Q2 | 82.5% | |
| 2018 | — | — | 1.049 | Q2 | 85.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2042-0188
ISSN
2042-0196
country
UScoverage
2010-2026